Bionutrion (CEO Kim Joo-young) announced that it will participate in ‘BIO KOREA 5’ held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
Bionutrion is developing a digital treatment device (Doctor Coach) that manages weight control and non-alcoholic fatty liver disease by utilizing a personalized nutrition evaluation program according to obesity and AI-based coaching. The meaning of ‘turning on (ON) the body’s metabolic switch in a healthy way through customized nutrition and coaching (BIO-NUTRI)’ was included in the mission. It is an aspiration to become a reliable digital coach that makes the body healthier through science-based weight control programs.
GreenProtake, to be introduced at this exhibition, has an amino acid score of 127 and is a low-calorie, high-protein dietary alternative that helps prevent muscle loss during dieting. In addition, Dr.Coach app was developed by a medical team specializing in obesity, a clinical nutritionist, and digital experts using GreenProtake. Doctor Coach evaluates the risk of non-alcoholic fatty liver disease and provides customized nutritional prescriptions considering daily lifestyle and health conditions. It is a systematic program using 1:1 coaching program and dietary replacement system. Unlike medicine, it was pointed out that the strength of Doctor Coach is that it provides fundamental treatment that makes the body healthier.
“Non-alcoholic fatty liver disease rarely leads to liver cirrhosis and liver cancer, and the incidence of diabetes and cardiovascular disease is 4 to 8 times higher,” said an official from Bionutrion. However, there is no cure yet, and weight loss is important as the primary treatment, but it is not easy to manage because there is no expert who can monitor patients according to their accompanying diseases so that they can lose weight in a healthy way.” is a one-year scientific research result and an evidence-based weight loss program composed of both an app and a dietary replacement.”
GreenProtake began to be sold in earnest from 2022 and has a market share of 1.3 million won based on production performance, and a market share of 2020% compared to 405 billion won in 0.3 production performance, but it was also emphasized that the product through hospitals and clinics is unique.
An official said, “I participated in this exhibition as a good opportunity to be selected for the Seoul National University Bundang Hospital K-Bio Health Regional Center Support Project. As BIO KOREA is a place where biohealth-related executives, researchers, and investors from around the world gather and share information, I hope it will serve as an opportunity to promote the company and its products,” he said.
“Currently, consumers can purchase GreenProtake, but it is mainly sold through hospitals and clinics. In the future, it plans to release weight control foods that can be sold directly to consumers. Even if the amino acid score is a little low, the protein amount is high and we are developing a delicious product that balances the three major nutrients,” he said. I would like to use coaching. We are preparing to be certified as a digital treatment device with the advantage of being able to receive care anytime, anywhere.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.